MORPHOLOGICAL ASPECTS IN EXFOLIATIVE  VAGINAL CYTOLOGY FOLLOWING ANTICANCEROUS CHEMOTHERAPY.
D000970:Antineoplastic Agents; D001388:Aziridines; D001943:Breast Neoplasms; D002467:Cell Nucleus; D004396:Coloring Agents; D003520:Cyclophosphamide; D005260:Female; D006689:Hodgkin Disease; D006801:Humans; D006965:Hyperplasia; D006984:Hypertrophy; D008433:Mathematics; D008558:Melphalan; D010051:Ovarian Neoplasms; D010336:Pathology; D013194:Staining and Labeling; D013852:Thiotepa; D014265:Triethylenemelamine; D014594:Uterine Neoplasms; D014626:Vaginal Smears
D000970:Antineoplastic Agents; D001388:Aziridines; D004396:Coloring Agents; D003520:Cyclophosphamide; D013852:Thiotepa; C026480:inproquone; D014265:Triethylenemelamine; D008558:Melphalan
ANTINEOPLASTIC AGENTS; BAYER E39; BREAST NEOPLASMS; CELL NUCLEUS; CYCLOPHOSPHAMIDE; HODGKIN'S DISEASE; HYPERTROPHY AND HYPERPLASIA; MATHEMATICS; MELPHALAN; OVARIAN NEOPLASMS; PATHOLOGY; STAINS AND STAINING; THIO-TEPA; TRIETHYLENE MELAMINE; UTERINE NEOPLASMS; VAGINAL SMEARS